Market Size of Cellular Health Screening Industry
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 8.70 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Cellular Health Screening Market Analysis
The cellular health screening market is expected to register a CAGR of 8.7% over the forecast period.
COVID-19 has had a significant impact on the growth of the market over the study period. The rise in preventive health awareness among the global population during the pandemic drives the market's growth. According to the NCBI article published in June 2022, the most common tests performed in the past 12 months were 83% of blood pressure measurements, 66.2% of blood sugar, 53.1% of urinalysis, and 55.1% of the liquid panel. The high number of preventive health screenings during the pandemic is expected to contribute to the growth of the market. In addition, the demand for cellular health screening is expected to remain undisturbed during the post-pandemic period owing to the rising preference for preventive healthcare, thereby contributing to the growth of the market over the next five years.
The growth of the market is attributed to rising applications of cellular health screening in personalized medicine and increasing government focus on preventive healthcare. The potential applications of cellular health screening in personalized medicine have provided significant growth opportunities to market players in this field. Along with the rapidly growing geriatric population, the demand for cellular screening is expected to rise during the forecast period. According to the United Nations Department of Economics and Social 2022 report, there were 771 million people aged 65 years or over globally in 2022, and the older population is projected to reach 994 million by 2030 and 1.6 billion by 2050. The growing geriatric population is more prone to chronic diseases, and thus, this increases the demand for preventive diagnostics, particularly cellular health screening.
Furthermore, the rising focus of the government on preventive care is expected to boost market growth further. For instance, in November 2022, the government of Haryana launched a mobile health screening initiative. The screening services include tests such as blood analysis, urine analysis, and HBA1C testing, among others. Such initiatives will lead to increased adoption of cellular health screening, driving the market growth.
Rising initiatives from the key market players are also expected to drive the cell health screening market. For instance, in November 2021, Menarini Silicon Biosystems commercially launched the CELL SEARCH laboratory-developed test for the enumeration of circulatory multiple myeloma cells for non-invasive monitoring of disease from whole blood. Such launches will therefore lead to increased adoption of cellular health screening tests, bolstering the market growth.
Thus, the above-mentioned factors are expected to drive the growth of the market over the forecast period. However, the risks associated with the transport of samples are expected to restrain the growth during the forecast period.
